Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Study ID
- NCT07010250
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- ANCA Associated Vasculitis
- Diabetic Nephropathies
- Extramembranous Glomerulopathy
- IgA Nephropathy
- Interstitial Nephritis
- Nephrotic Syndrome, Minimal Change
- Segmental Hyalinosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Study Details
The project is to explore in humans the hypothesis of the link between the alteration of tubulo-interstitial metabolism and the rate of deterioration of renal function by comparing various nephropathies.
Key Dates
- Start date
- Jun 2, 2025
- Status verified
- May 2025
- Primary completion
- Jun 2, 2029
- Completion
- Jun 2, 2029
Study Design
- Enrollment
- 146 participants (estimated)
Arms
- Arm: ANCA Associated VasculitisCase
- Arm: Extramembranous GlomerulopathyControl
- Arm: Nephrotic Syndrome, Minimal ChangeControl
- Arm: Interstitial NephritisControl
- Arm: IgA NephropathyControl
- Arm: Segmental HyalinosisControl
- Arm: Diabetic NephropathyControl
Primary Outcome Measure
Spatial lipidomics for measuring tubular dysmetabolism [ Time Frame: Through study completion up to end of study, when the last patients completed 1 year follow-up. ]
Central Contacts
- Maxime BRUSSIEUX+33 1 44 84 17 89
- Laura LE MAO+33 1 56 09 54 97
Related Studies
- Transformative Research in Diabetic NephropathyRecruiting · University of Pennsylvania · Little Rock, Arkansas
- Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.Recruiting · University of Michigan · Ann Arbor, Michigan
- Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up StudyEnrolling By Invitation · University of Colorado, Denver · Aurora, Colorado
- Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney DiseasePHASE3 · Recruiting · Alessandro Doria · Stanford, California